1. Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies

   • Ulrike Bacher
   • Claudia Haferlach
   • Torsten Haferlach

   Review Article 02 March 2010 Pages: 643 - 652

   

2. Mechanisms of resistance against PKC412 in resistant FLT3-ITD positive human acute myeloid leukemia cells

   • Friedrich Stölzel
   • Christine Steudel
   • Christian Thiede

   Original Article 30 January 2010 Pages: 653 - 662

   

3. Expression of pSTAT5 predicts FLT3 internal tandem duplications in acute myeloid leukemia

   • Ellen Christina Obermann
   • Caroline Arber
   • Alexandar Tzankov

   Original Article 12 January 2010 Pages: 663 - 669

   

4. Mean corpuscular volume predicts prognosis in MDS patients with abnormal karyotypes

   • Hong Wang
   • XiaoQin Wang
   • GuoWei Lin

   Original Article 24 February 2010 Pages: 671 - 679

   

5. Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment

   • Joon Ho Moon
   • Shi Nae Kim
   • Sang Kyun Sohn

   Original Article 17 March 2010 Pages: 681 - 689

   

6. A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs

   • Elena Crisà
   • Ermanno Venturino
   • Dario Ferrero

   Original Article 10 February 2010 Pages: 691 - 699

   

7. Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy

   • Kevin Kemp
   • Ruth Morse
   • Craig Donaldson

   Original Article 30 January 2010 Pages: 701 - 713

   

8. Poor potential of proliferation and differentiation in bone marrow mesenchymal stem cells derived from children with severe aplastic anemia

   • Yu-Hua Chao
   • Ching-Tien Peng
   • Kang-Hsi Wu

   Original Article 19 January 2010 Pages: 715 - 723

   

9. Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib

   • Youngil Koh
   • Inho Kim
   • Korean Society of Hematology CML working party

   Original Article 24 February 2010 Pages: 725 - 731

   

10. Idiopathic neutropenia with fewer than 5% dysplasia may be a distinct entity of idiopathic cytopenia of undetermined significance

    • Keiko Ando
    • Atsushi Kodama
    • Kazuma Ohyashiki

    Letter to the Editor 13 October 2009 Pages: 733 - 735

    

11. Resolution of invasive fungal sinusitis in immunocompromised patients: neutrophil count is crucial beside a combined medical and surgical approach

    • Patrizia Zappasodi
    • Marianna Rossi
    • Mario Lazzarino

    Letter to the Editor 07 November 2009 Pages: 737 - 739

    

12. Jumping translocation involving 1q21 during long-term complete remission of acute myeloid leukemia

    • Sumimasa Nagai
    • Yasuhito Nannya
    • Mineo Kurokawa

    Letter to the Editor 11 November 2009 Pages: 741 - 742

    

13. Acquired erythropoietic protoporphyria

    • Daniel Blagojevic
    • Thomas Schenk
    • Franz Trautinger

    Letter to the Editor 10 November 2009 Pages: 743 - 744

    

14. Imatinib and cardiac failure in idiopathic hypereosinophilic syndrome

    • Lisa Pieri
    • Alberto Bosi
    • Alessandro M. Vannucchi

    Letter to the Editor 02 December 2009 Pages: 745 - 746

    

15. ABO discrepancy in an elderly patient with IgA kappa-type multiple myeloma

    • So Young Kim
    • Seung Hwan Oh
    • Tae Sung Park

    Letter to the Editor 11 November 2009 Pages: 747 - 748